Andrew Combs - 13 Dec 2021 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
EVP, Head of Chemistry
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
Issuer symbol
PRLD
Transactions as of
13 Dec 2021
Net transactions value
+$94,880
Form type
4
Filing time
15 Dec 2021, 16:21:43 UTC
Previous filing
22 Jul 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRLD Common Stock Purchase $48,480 +4,000 +1.5% $12.12 264,380 13 Dec 2021 Direct F1
transaction PRLD Common Stock Purchase $46,400 +4,000 +1.5% $11.60 268,380 14 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.